NCT06222086

Brief Summary

Type 2 diabetes (T2DM) is a metabolic disease characterized by chronic hyperglycemia that occurs as a result of any disorder in insulin secretion or insulin activity. Regular physical activity is important in preventing and managing this disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 25, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 24, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

May 20, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 25, 2023

Last Update Submit

December 29, 2025

Conditions

Keywords

Type 2 diabetesCalisthenic Exercise TrainingOxygen consumptionMuscle oxygen

Outcome Measures

Primary Outcomes (4)

  • Oxygen consumption

    Maximum exercise capacity will be assessed by symptom-limited cardiopulmonary exercise testing on a treadmill at gradually increasing speed and degree, and oxygen consumption will be measured during the test.

    through study completion, an average of 2 year

  • Muscle oxygenation

    Before the cardiopulmonary exercise test during and after the tests the muscle oxygenation will be measured by using a near-infrared spectroscopy device.

    through study completion, an average of 2 year

  • Muscle oxygenation

    Before the 6-minute pegboard and ring test (6-PBRT) during and after the tests the muscle oxygenation will be measured by using a near-infrared spectroscopy device.

    through study completion, an average of 2 year

  • Physical activity level assessment with multi-sensor activity tracking

    A multi-sensor activity monitor will be used to assess the level of physical activity

    through study completion, an average of 2 year

Secondary Outcomes (21)

  • Upper extremity functional exercise capacity

    through study completion, an average of 2 year

  • Pulmonary function (Forced expiratory volume in the first second (FEV1))

    through study completion, an average of 2 year

  • Pulmonary function (Forced vital capacity (FVC))

    through study completion, an average of 2 year

  • Pulmonary function (FEV1 / FVC)

    through study completion, an average of 2 year

  • Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%))

    through study completion, an average of 2 year

  • +16 more secondary outcomes

Study Arms (2)

Calisthenic exercise training with telerehabilitation

EXPERIMENTAL

The training group will be given calisthenic exercise training via video conference accompanied by a physiotherapist for 6 weeks.

Other: Calisthenic exercise training with telerehabilitation

Control Group

SHAM COMPARATOR

The control group will not be given any training for 6 weeks during the study period

Other: Control Group

Interventions

The training group will be given calisthenic exercise training 30-45 minutes a day, 3 days a week, via video conference, accompanied by a physiotherapist, for 6 weeks. The training workload of aerobic exercise training will be applied at 60-80% of peak heart rate, with dyspnea 3-4 points or fatigue 4-6 points according to the Modified Borg Scale (MBS). Blood sugar measurement will be taken before exercise training. People whose blood sugar result is \>300 mg/dL will not be allowed to exercise that day.

Calisthenic exercise training with telerehabilitation

The control group will not be given any training during the 6-week period. After the study, the treatment applied to the training group will also be applied to the control group in order to ensure that the patients in the control group are not ethically deprived of rehabilitation.

Control Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with T2DM,
  • Aged between 18-65 years,
  • Able to walk and cooperate,
  • Patients who volunteer to participate in the study.

You may not qualify if:

  • Body mass index \>40 kg/m2,
  • A known lung disease,
  • Serious neurological, neuromuscular, orthopedic, or other diseases affecting physical functions,
  • Cognitive impairment that causes them to have difficulty understanding and following exercise test instructions,
  • Having had any cardiac event or surgery in the last six months,
  • Participated in a planned exercise program within the last three months,
  • Uncontrolled hypertension,
  • An acute pulmonary exacerbation within the last 4 weeks, have an acute upper or lower respiratory tract infection,
  • Presence of diabetes complications such as nephropathy, retinopathy and severe neuropathy,
  • Contraindications for exercise testing and/or exercise training according to the American College of Sports Medicine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit

Ankara, Çankaya, 06490, Turkey (Türkiye)

Location

Related Publications (7)

  • Pan B, Ge L, Xun YQ, Chen YJ, Gao CY, Han X, Zuo LQ, Shan HQ, Yang KH, Ding GW, Tian JH. Exercise training modalities in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. Int J Behav Nutr Phys Act. 2018 Jul 25;15(1):72. doi: 10.1186/s12966-018-0703-3.

    PMID: 30045740BACKGROUND
  • Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, Kirwan JP, Zierath JR. Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022 Feb 1;54(2):353-368. doi: 10.1249/MSS.0000000000002800.

    PMID: 35029593BACKGROUND
  • Amadid H, Johansen NB, Bjerregaard AL, Brage S, Faerch K, Lauritzen T, Witte DR, Sandbaek A, Jorgensen ME, Vistisen D. The role of physical activity in the development of first cardiovascular disease event: a tree-structured survival analysis of the Danish ADDITION-PRO cohort. Cardiovasc Diabetol. 2018 Sep 12;17(1):126. doi: 10.1186/s12933-018-0769-x.

    PMID: 30208900BACKGROUND
  • Ibanez J, Izquierdo M, Arguelles I, Forga L, Larrion JL, Garcia-Unciti M, Idoate F, Gorostiaga EM. Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes Care. 2005 Mar;28(3):662-7. doi: 10.2337/diacare.28.3.662.

    PMID: 15735205BACKGROUND
  • Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, Fallucca S, Alessi E, Letizia C, Jimenez A, Fallucca F, Pugliese G. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis. 2010 Oct;20(8):608-17. doi: 10.1016/j.numecd.2009.04.015. Epub 2009 Aug 19.

    PMID: 19695853BACKGROUND
  • Ur Rehman SS, Karimi H, Gillani SA, Ahmad S. Effects of supervised structured aerobic exercise training programme on level of Exertion, dyspnoea, VO2 max and Body Mass Index in patients with type 2 diabetes mellitus. J Pak Med Assoc. 2017 Nov;67(11):1670-1673.

    PMID: 29171557BACKGROUND
  • Kirwan JP, Solomon TP, Wojta DM, Staten MA, Holloszy JO. Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E151-6. doi: 10.1152/ajpendo.00210.2009. Epub 2009 Apr 21.

    PMID: 19383872BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

TelerehabilitationControl Groups

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesTelemedicineDelivery of Health CarePatient Care ManagementHealth Services AdministrationEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Ayşenur SARISAKALOĞLU, MSc

    Gazi University

    STUDY CHAIR
  • Fidan YILMAZ, MSc

    Gazi University

    PRINCIPAL INVESTIGATOR
  • Füsun BALOŞ TÖRÜNER, Prof. Dr.

    Gazi University

    PRINCIPAL INVESTIGATOR
  • Meral BOŞNAK GÜÇLÜ, Prof. Dr.

    Gazi University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Triple-blind study; the patients will not be informed about training group or control group and they will be evaluated and trained at different places and times.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study director, PT, PhD, Prof.Dr. Faculty of Health Sciences, Department of Cardiopulmonary Physiotherapy and Rehabilitation

Study Record Dates

First Submitted

December 25, 2023

First Posted

January 24, 2024

Study Start

May 20, 2024

Primary Completion

May 30, 2025

Study Completion

September 15, 2025

Last Updated

January 2, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations